共 50 条
- [1] Finerenone for Patients With CKD and Type 2 Diabetes [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (08): : 713 - 713
- [2] Cardiorenal Outcomes With Finerenone in Asian Patients With CKD and Type 2 Diabetes: Post Hoc Analysis From FIDELIO-DKD [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 678 - 678
- [6] Finerenone and Kidney Outcomes in Patients with CKD and Type 2 Diabetes: Results from FIGARO-DKD [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 45 - 45
- [7] Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes A FIDELITY Subgroup Analysis [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (05): : 602 - 612
- [9] EU Approval granted for Finerenone for the Treatment of CKD in Type 2 Diabetes [J]. DIABETES STOFFWECHSEL UND HERZ, 2022, 31 (02): : 132 - 132
- [10] Counteracting aldosterone in cardiorenal disease in type 2 diabetes through finerenone administration [J]. HIPERTENSION Y RIESGO VASCULAR, 2023, 40 (02): : 55 - 57